Organogenesis Holdings Inc. (ORGO)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.44
-2.70%
Mkt Cap $182.72M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (6 analysts)
$2.50
Range $2.00 – $3.00
Implied Upside
+73.6%
Consensus $2.50 vs current $1.44